Brought to you by 
Series D leads to $15mm for Barrx Medical
19 Aug 2010
Executive Summary
Barrx Medical Inc. (endoscopic treatments for gastrointestinal diseases) completed a $15mm Series D financing round led by first-time investors Highland Capital Partners, which adds a board member and was joined by returning shareholders Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, and Greenspring Associates. The company will utilize the funds to identify new applications for its HALO bipolar radiofrequency technology and expand its use into new markets around the world.
Deal Industry
- Medical Devices
-
Medical Devices
- Radiofrequency Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series D leads to $15mm for Barrx Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice